SXL
CVS icon

Summit X LLC’s CVS Health CVS Stock Holding History

Summit X LLC’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,825
Closed -$264K – 48
2025
Q2 		$264K Buy
3,825
+411
+12% +$27K 0.05% 209
2025
Q1 		$231K Buy
+3,414
New +$204K 0.05% 202
2024
Q4 		– Sell
-29,281
Closed -$1.73M – 219
2024
Q3 		$1.73M Sell
29,281
-3,871
-12% -$226K 0.42% 46
2024
Q2 		$1.96M Buy
33,152
+4,175
+14% +$261K 0.44% 43
2024
Q1 		$2.31M Buy
28,977
+1,403
+5% +$107K 0.59% 36
2023
Q4 		$2.18M Sell
27,574
-26
-0.1% -$1.85K 0.62% 31
2023
Q3 		$1.93M Buy
27,600
+22,799
+475% +$1.62M 0.61% 31
2023
Q2 		$332K Sell
4,801
-125
-3% -$8.89K 0.08% 201
2023
Q1 		$366K Sell
4,926
-63
-1% -$5.28K 0.09% 189
2022
Q4 		$463K Sell
4,989
-83
-2% -$8.01K 0.13% 159
2022
Q3 		$483K Buy
5,072
+81
+2% +$8.02K 0.14% 157
2022
Q2 		$461K Sell
4,991
-33
-0.7% -$3.22K 0.13% 159
2022
Q1 		$508K Sell
5,024
-60
-1% -$6.3K 0.12% 162
2021
Q4 		$522K Sell
5,084
-34
-0.7% -$3.14K 0.12% 166
2021
Q3 		$430K Sell
5,118
-43
-0.8% -$3.6K 0.11% 186
2021
Q2 		$438K Sell
5,161
-108
-2% -$8.84K 0.11% 185
2021
Q1 		$394K Sell
5,269
-5,500
-51% -$401K 0.11% 189
2020
Q4 		$742K Buy
+10,769
New +$700K 0.22% 111
2020
Q2 		$323K Buy
4,971
+776
+18% +$48.9K 0.12% 161
2020
Q1 		$249K Sell
4,195
-26,462
-86% -$1.77M 0.12% 155
2019
Q4 		$2.27M Sell
30,657
-2,111
-6% -$148K 0.84% 31
2019
Q3 		$2.07M Buy
32,768
+2,906
+10% +$172K 0.83% 33
2019
Q2 		$1.64M Buy
29,862
+1,957
+7% +$105K 0.67% 40
2019
Q1 		$1.5M Buy
27,905
+15,732
+129% +$971K 0.64% 43
2018
Q4 		$797K Buy
12,173
+4,379
+56% +$327K 0.46% 54
2018
Q3 		$633K Buy
7,794
+3,853
+98% +$275K 0.31% 80
2018
Q2 		$254K Buy
+3,941
New +$260K 0.14% 167

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Summit X LLC's CVS Position: Q3 2025 in Review

Summit X LLC sold out of CVS Health (CVS) in Q3 2025, closing a stake of 3,825 shares — an estimated $264K sold.

Summit X LLC first reported a position in CVS in Q2 2018 and held it in 27 quarters. The position peaked at $2.31M in Q1 2024. 1,837 funds tracked by Wall St. Rank hold CVS as of Q3 2025.

  • Summit X LLC reported no remaining CVS Health position as of Q3 2025 after selling out during the quarter.
  • Summit X LLC sold 3,825 CVS Health shares in Q3 2025, an estimated $264K.
  • Summit X LLC first reported a position in CVS Health in Q2 2018 and held it in 27 quarters.
  • Summit X LLC's CVS Health position peaked at $2.31M in Q1 2024.
  • 1,837 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.

Based on Summit X LLC's 13F filing for Q3 2025.